A Phase 3, Double-blind, Randomised, Parallel-group, Placebo-controlled Study of Oral Weekly Alendronate for the Prevention of Androgen Deprivation Bone Loss in Nonmetastatic Prostate Cancer: The Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) Study

Published 2012 View Full Article

Authors

Keywords

Journal

EUROPEAN UROLOGY

Volume 63, Issue 5, Pages 927-935

Publisher

Elsevier BV

Online

2012-09-12

DOI

10.1016/j.eururo.2012.09.007

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

EUROPEAN UROLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Discover Peeref hubs

Create your own webinar